Sweetgreen NYSE: SG reported second-quarter 2026 revenue of $192.7 million, up approximately 4% from a year earlier, while comparable restaurant sales declined 6.2%. The company said transaction trends improved sequentially during the quarter, reaching roughly flat comparable transactions in June, but momentum was disrupted in mid-July by consumer concerns surrounding a Cyclospora outbreak attributed to iceberg lettuce.
While the top- and bottom-line numbers for Sweetgreen (SG) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
As the cyclosporiasis outbreak continues to rage across the United States, salad chains like Sweetgreen are preparing for a significant decline in sales.
For the second quarter ending June 28, Sweetgreen's same-store sales fell 6.2% – its sixth straight decline.
Sweetgreen, Inc. (SG) Q2 2026 Earnings Call Transcript
Sweetgreen, Inc. (SG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago.
Sweetgreen cut its full-year outlook as consumers' cyclospora fears weighed on its sales. The salad chain has not been implicated in the ongoing outbreak.
Sweetgreen (SG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the closing of the recent trading day, Sweetgreen, Inc. (SG) stood at $6.17, denoting a +2.83% move from the preceding trading day.
In the closing of the recent trading day, Sweetgreen, Inc. (SG) stood at $6.65, denoting a -6.07% move from the preceding trading day.
U.S. regulators walked back its findings about contaminated lettuce, saying that the Taylor Farms sample initially reported as positive for cyclospora was actually a false positive.
Sweetgreen (SG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.